Biodexa Pharmaceuticals (BDRX) Receivables (2013 - 2026)
Biodexa Pharmaceuticals (BDRX) posted Receivables of $3.94 million for the quarter ended Jun 30, 2026, down 34.3% from $6 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Receivables (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Biodexa Pharmaceuticals' Receivables came in at $5.08 million, down 40.7% from the prior year.
- Annual Receivables shows a five-year compound annual growth rate of 38.0% (years ended Dec 2020 to Dec 2025).
- In prior years, Biodexa Pharmaceuticals' Receivables was $8.56 million in the year ended Dec 31, 2024 (+649.1%), $1.14 million in the year ended Dec 31, 2023 (-29.3%), $1.62 million in the year ended Dec 31, 2022 (-17.7%) and $1.96 million in the year ended Dec 31, 2021 (+93.4%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Receivables since the quarter ended Jun 30, 2024.
- On a year-over-year basis, Receivables increased in two of the last four quarters, with growth averaging 181.5%.
- The strongest year-over-year quarter for Receivables in the past five years was the quarter ended Dec 31, 2024, with growth of 653.8%; the weakest was the quarter ended Dec 31, 2025, with a decline of 40.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.06 Bn | 1,102.65 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.24 Bn | 321.62 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.48 Bn | 235.17 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Biodexa Pharmaceuticals | 3,986.00 | -23.40 Mn | - | 3.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.89 Mn |
| Dec 31, 2025 | 5.18 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Dec 31, 2024 | 8.41 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Dec 31, 2022 | 1.58 Mn |
| Dec 31, 2021 | 1.93 Mn |
| Jun 30, 2021 | 1.94 Mn |
| Dec 31, 2020 | 1.08 Mn |
| Jun 30, 2020 | 4.52 Mn |
| Dec 31, 2019 | 5.82 Mn |
| Jun 30, 2019 | 3.83 Mn |
| Dec 31, 2018 | 3.66 Mn |
| Jun 30, 2018 | 940,102.70 |
| Dec 31, 2017 | 5.50 Mn |
| Jun 30, 2017 | 3.36 Mn |
| Dec 31, 2016 | 4.07 Mn |
| Jun 30, 2016 | 2.02 Mn |
API Access
Biodexa Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();